186
Views
1
CrossRef citations to date
0
Altmetric
Diagnostics

Predictors of methacholine challenge testing results in subjects without airflow obstruction

, BHSc, , Phd & , MD
Pages 2060-2068 | Received 13 May 2021, Accepted 26 Sep 2021, Published online: 09 Oct 2021

References

  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2020. (report). [accessed 2021 Jan 22]. www.ginasthma.org.
  • Lougheed M, Lemiere C, Ducharme F, Licskai C, Dell S, Rowe B, Fitzgerald JM, Leigh R, Watson W, Boulet L-P, Canadian Thoracic Society Asthma Clinical Assembly. Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults. Can Respir J. 2012;19(2):127–164. doi:10.1155/2012/635624.
  • British Thoracic Society. British guideline on the management of asthma; 2019. (report). [accessed 2021 Jan 22]. www.brit-thoracic.org.uk.
  • Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. J Allergy Clin Immunol. 1992;89(1):23–30. doi:10.1016/S0091-6749(05)80037-5.
  • Nieminen MM. Unimodal distribution of bronchial hyperresponsiveness to methacholine in asthmatic patients. Chest. 1992;102(5):1537–1543. doi:10.1378/chest.102.5.1537.
  • Thériault R, Raz A. Patterns of bronchial challenge testing in Canada. CJRT. 2018;54(2):41–47. doi:10.29390/cjrt-2018-006.
  • Crapo R, Casaburi R, Coates A, Enright P, Hankinson J, Irvin C, MacIntyre N, McKay R, Wanger J, Anderson S, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309–329. doi:10.1164/ajrccm.161.1.ats11-99.
  • Coates A, Wanger J, Cockcroft DW, Culver B, Diamant Z, Gauvreau G, Hall G, Hallstrand T, Horvath I, de Jongh F, the Bronchoprovocation Testing Task Force, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526. doi:10.1183/13993003.01526-2016.
  • Quanjer P, Stanojevic S, Cole T, Baur X, Hall G, Culver B, Enright P, Hankinson J, Ip M, Zheng J, ERS Global Lung Function Initiative, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations . Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312.
  • Miller M, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten C, Gustafsson P, ATS/ERS Task Force, et al. General considerations for lung function testing. Eur Respir J. 2005;26(1):153–161. doi:10.1183/09031936.05.00034505.
  • Pellegrino R, Viegi G, Jensen R, Johnson D, MacIntyre N, McKay R, Miller M, Navajas D, Pedersen O, Wanger J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205.
  • Wanger J, Clausen J, Coates A, Pedersen O, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten C, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–522. doi:10.1183/09031936.05.00035005.
  • Morgado R, Oliveira C, Campanha R, Moreira S, Staats R, Escaleira D, Valença J, Bárbara C. Predictive factors of a positive methacholine challenge response based on data from a baseline respiratory function test. Eur Respir J. 2015;46(suppl):PA609. [abstract]. doi:10.1183/13993003.congress-2015.PA609.
  • Hardaker K, Downie S, Kermode J, Farah C, Brown N, Berend N, King G, Salome C. Predictors of airway hyperresponsiveness differ between old and young patients with asthma. Chest. 2011;139(6):1395–1401. doi:10.1378/chest.10-1839.
  • Schwartz J, Schindler C, Zemp E, Perruchoud AP, Zellweger J-P, Wüthrich B, Leuenberger P, Ackermann-Liebrich U. Predictors of methacholine responsiveness in a general population. Chest. 2002;122(3):812–820. doi:10.1378/chest.122.3.812.
  • Burgess JA, Matheson MC, Diao F, Johns DP, Erbas B, Lowe AJ, Gurrin LC, Lodge CJ, Thomas PS, Morrison S, et al. Bronchial hyperresponsiveness and obesity in middle age: insights from an Australian cohort. Eur Respir J. 2017;50(3):1602181. doi:10.1183/13993003.02181-2016.
  • Centers for Disease Control and Prevention. Asthma data visualizations. 2020. [accessed 2021 Jan 22]. https://www.cdc.gov/asthma/data-visualizations/default.htm.
  • Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep. 2017;17(3):19. doi:10.1007/s11882-017-0686-1.
  • Zein JG, Erzurum SC. Asthma is different in women. Curr Allergy Asthma Rep. 2015;15(6):28. doi:10.1007/s11882-015-0528-y.
  • Shah N, Manek G, Stettmeier KD, Datta D. Demographic and spirometric characteristics of patients with positive and negative methacholine challenge test. Am J Respir Crit Care Med. 2020;201:A5643–A5643. [abstract]. doi:10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A5643.
  • Vijayan K, Shrestha P, Bautista M, Goldstein L, Neupane B. Association of BMI with airways hyper-responsive to methacholine [abstract]. Chest. 2016;149(4):A13. doi:10.1016/j.chest.2016.02.015.
  • Neder JA, Berton DC, O’Donnell DE. Obesity: how pulmonary function tests may let us down. J Bras Pneumol. 2020;46(3):e20200116.
  • Saint-Pierre M, Ladha J, Berton DC, Reimao G, Castelli G, Marillier M, Bernard A-C, O’Donnell DE, Neder JA. Is the slow vital capacity clinically useful to uncover airflow limitation in subjects with preserved FEV1/FVC ratio? Chest. 2019;156(3):497–506. doi:10.1016/j.chest.2019.02.001.
  • D’urzo K, Chen A, D’Urzo A. Lung function among patients with and without airway hyperresponsiveness in primary care [abstract]. Chest. 2019;155(6):A381. doi:10.1016/j.chest.2019.04.082.
  • Litonjua AA, Sparrow D, Weiss ST. The FEF25-75/FVC ratio is associated with methacholine airway responsiveness: the Normative Aging Study. Am J Respir Crit Care Med. 1999;159(5):1574–1579. doi:10.1164/ajrccm.159.5.9803063.
  • Stanbrook MB, Chapman KR, Kesten S. Gas trapping as a predictor of positive methacholine challenge in patients with normal spirometry results. Chest. 1995;107(4):992–995. doi:10.1378/chest.107.4.992.
  • Collard P, Njinou B, Nejadnik B, Keyeux A, Frans A. Single breath diffusing capacity for carbon monoxide in stable asthma. Chest. 1994;105(5):1426–1429. doi:10.1378/chest.105.5.1426.
  • Neder JA, Berton DC, Muller PT, O’Donnell DE. Incorporating lung diffusing capacity for carbon monoxide in clinical decision making in chest medicine. Clin Chest Med. 2019;40(2):285–305. doi:10.1016/j.ccm.2019.02.005.
  • FitzGerald JM, Lemiere C, Lougheed MD, Ducharme FM, Dell SD, Ramsey C, Yang MCL, Côté A, Watson W, Olivenstein R, et al. Recognition and management of severe asthma: A Canadian Thoracic Society position statement. Can J Respir Crit Care Sleep Med. 2017;1(4):199–221. doi:10.1080/24745332.2017.1395250.
  • Bourbeau J, Bhutani M, Hernandez P, Aaron SD, Balter M, Beauchesne M-F, D’Urzo A, Goldstein R, Kaplan A, Maltais F, et al. Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Can J Respir Crit Care Sleep Med. 2019;3(4):210–232. doi:10.1080/24745332.2019.1668652.
  • Kovalszki A, Weller PF. Eosinophilia. Prim Care. 2016;43(4):607–617. doi:10.1016/j.pop.2016.07.010.
  • Annema JT, Sparrow D, O’Connor GT, Rijcken B, Koëter GH, Postma DS, Weiss ST. Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: The Normative Aging Study. Eur Respir J. 1995;8(1):62–69. doi:10.1183/09031936.95.08010062.
  • Schwartz N, Grossman A, Levy Y, Schwarz Y. Correlation between eosinophil count and methacholine challenge test in asymptomatic subjects. J Asthma. 2012;49(4):336–341. doi:10.3109/02770903.2012.672613.
  • Cockcroft DW. Methacholine challenge. Clin Pulm Med. 2007;14(1):1–6. doi:10.1097/01.cpm.0000252840.59547.29.
  • Sumino K, Sugar EA, Irvin CG, Kaminsky DA, Shade D, Wei CY, Holbrook JT, Wise RA, Castro M, American Lung Association Asthma Clinical Research Centers. Methacholine challenge test: Diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol. 2012;130(1):69–75. doi:10.1016/j.jaci.2012.02.025.
  • Cockcroft DW. Methacholine challenge testing in the diagnosis of asthma. Chest. 2020;158(2):433–434. doi:10.1016/j.chest.2020.04.034.
  • McGrath KW, Fahy JV. Negative methacholine challenge tests in subjects who report physician-diagnosed asthma. Clin Exp Allergy. 2011;41(1):46–51. doi:10.1111/j.1365-2222.2010.03627.x.
  • Cockcroft DW, Davis B. Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol. 2009;103(5):363–369. doi:10.1016/S1081-1206(10)60353-5.
  • Aaron SD, Vandemheen KL, Boulet L-P, McIvor RA, Fitzgerald JM, Hernandez P, Lemiere C, Sharma S, Field SK, Alvarez GG, Canadian Respiratory Clinical Research Consortium, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008;179(11):1121–1131. doi:10.1503/cmaj.081332.
  • Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, Canadian Respiratory Research Network, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317(3):269–279. doi:10.1001/jama.2016.19627.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.